- US12545705utility2026IBAT Inhibitors for the Treatment of Liver Diseases0 cites
- US12508234utility2025Pharmaceutical Formulation of Odevixibat0 cites
- US12447156utility2025Treating Progressive Familial Intrahepatic Cholestasis (PFIC) with IBAT Inhibitors0 cites
- US12365658utility2025Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
- US12202809utility2025Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
- US12187690utility2025Benzothiadiazepine Compounds and Their Use as Bile Acid Modulators0 cites
- US12187812utility2025IBAT Inhibitors for the Treatment of Liver Diseases0 cites
- US12134606utility2024Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
- US12091394utility2024Crystal Modifications of Odevixibat0 cites
- US12060338utility2024Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
- US12024495utility2024Benzothiazepine Compounds and Their Use as Bile Acid Modulators0 cites
- US11891368utility2024Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
- US11801226utility2023Pharmaceutical Formulation of Odevixibat0 cites
- US11802115utility2023Pharmaceutical Formulation of Odevixibat0 cites
- US11773071utility2023Benzothiazepine Compounds and Their Use as Bile Acid Modulators0 cites
- US11732006utility2023IBAT Inhibitors for the Treatment of Liver Diseases0 cites
- US11708340utility2023Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
- US11603359utility2023Benzothiadiazepine Compounds and Their Use as Bile Acid Modulators0 cites
- US11583539utility2023Treating Progressive Familial Intrahepatic Cholestasis (PFIC) with IBAT Inhibitors0 cites
- US11572350utility2023Benzothia(di)azepine Compounds and Their Use as Bile Acid Modulators0 cites
Page 1 of 2Next →